Imatinib for the treatment of unresectable and/or metastatic gastrointestinal stromal tumours

Technology appraisal guidance
Reference number: TA209
Published: 24 November 2010

Gastro-intestinal stromal tumours (unresectable/metastatic) - imatinib (review): responses from the Assessment Group

Gastro-intestinal stromal tumours (unresectable/metastatic) - imatinib (review): responses from the Assessment Group

Gastro-intestinal stromal tumours (unresectable/metastatic) - imatinib (review): responses from the Assessment Group
16 September 2010
(106.54 Kb 31 sec)

Adobe Acrobat reader required.

Adobe Acrobat reader required.

This page was last updated: 13 September 2010